Patients with type 2 diabetes making first pharmacy claim for basal insulin, included if previously on GLP-1 analogs/oral hypoglycaemic agentes and had at least 2 years of Medicare Advantage coverage.Mean age 72 years.Excluded: previous insulin use (prandial insulin use during follow-up was permitted). This evidence concerns the gene INS and type 2 diabetes mellitus.